May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Visual Recovery in Patients Undergoing 25–Gauge Transconjunctival Vitrectomy
Author Affiliations & Notes
  • M.J. Ward
    Ophthalmology, Case Western Reserve University, Cleveland, OH
  • L. Rao
    Ophthalmology, Case Western Reserve University, Cleveland, OH
  • F. Seffo
    Ophthalmology, Case Western Reserve University, Cleveland, OH
  • K. Jamal
    Ophthalmology, Case Western Reserve University, Cleveland, OH
  • S. Huang
    Ophthalmology, Case Western Reserve University, Cleveland, OH
  • Footnotes
    Commercial Relationships  M.J. Ward, None; L. Rao, None; F. Seffo, None; K. Jamal, None; S. Huang, Alcon, Bausch & Lomb, C; Genentech, Bausch & Lomb, Cambridge Antibody Technologies, Eyetech/Pfizer, R.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 4646. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.J. Ward, L. Rao, F. Seffo, K. Jamal, S. Huang; Visual Recovery in Patients Undergoing 25–Gauge Transconjunctival Vitrectomy . Invest. Ophthalmol. Vis. Sci. 2006;47(13):4646.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : This series evaluates visual recovery time in eyes undergoing 25–guage transconjunctival vitrectomy for a variety of posterior segment conditions.

Methods: : A retrospective chart review of the first 98 consecutive patients (98 eyes) that underwent 25–guage vitrectomy using the Bausch & Lomb Millenium TSV 25 system by a single author (SH) for nonclearing vitreous hemorrhage (52), epiretinal membrane (13), TRD (9), vitreous opacities (8), rhegmatogenous retinal detachment (6), CRVO (5), endophthalmitis (2), ROP (1), BRAO (1), and BRVO (1) was performed. Best–corrected pre– and postoperative visual acuity were converted to logMAR values. The first postop visit in which visual acuity exceeded that of preoperative visual acuity was noted. Additional outcome measures were performed and included intraocular pressure, use of post–op glaucoma medications and postoperative complications.

Results: : The average time from surgery to achieve better than preoperative vision for all patients was 12.4 days (range1–77). Factors limiting recovery of vision following surgery included intraocular gas bubble (14/98), post–op VH (8/98), and macular ischemia (25/98); excluding these patients, mean time to achieve better than preoperative vision was 8.6 days (range 1–64). Of these patients, 61% had better than pre–op vision on the first post–op day and 82% by the first week visit. A total of 77/98 (78.5%) patients achieved better than preoperative vision at some point during their postoperative course. Mean preoperative visual acuity improved from 20/458 (range 20/20–LP, median 20/400, mode 2/200) to 20/102 (range 20/20–LP, median 20/50, mode 20/40) postoperatively (P<0.0001). Complications included retinal detachment (4/98), elevated IOP (18/98), and transient hypotony (9/98). Mean follow–up time was 128 days (range 7–761).

Conclusions: : Rapid and highly significant visual recovery occurred in the absence of underlying vision–limiting pathology. Complications were rare and compared favorably with published literature on 20–gauge surgery. A comparative study evaluating visual recovery time in patients undergoing 20–gauge vitrectomy will be discussed.

Keywords: vitreoretinal surgery 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×